Rodriguez Julio C, Peterman James E, Fleenor Bradley S, Whaley Mitchell H, Kaminsky Leonard A, Harber Matthew P
Clinical Exercise Physiology, Human Performance Laboratory, Ball State University, Muncie, Indiana, USA.
Fisher Institute of Health and Well-Being, Ball State University, Muncie, Indiana, USA.
Metab Syndr Relat Disord. 2022 Sep;20(7):414-420. doi: 10.1089/met.2021.0130. Epub 2022 May 6.
The association between cardiorespiratory fitness (CRF) and metabolic syndrome (MetSyn) is well established. Additional variables derived from cardiopulmonary exercise testing (CPET) have shown prognostic value in some chronic diseases, however, there is limited information on how cardiopulmonary responses to exercise may be altered in individuals with MetSyn. Thus, the purpose of this study was to examine the association between cardiopulmonary variables derived from CPET and MetSyn. A cohort of 3181 participants (1714 men, 1467 women), aged 20-79 years, completed CPET and metabolic risk factor assessment between January 1, 1971, and November 1, 2020. Cardiopulmonary variables assessed included CRF defined as the maximum volume of oxygen uptake (VO), ventilatory threshold (VO@VT), oxygen uptake efficiency slope (OUES), the ratio of ventilation to VO at peak exercise (peak V/VO) and the V/VCO. MetSyn was defined using the National Cholesterol Education Program/Adult Treatment Panel. VO, VO@VT, and OUES were lower ( < 0.001) and V/VCO was higher ( < 0.001) in individuals with MetSyn ( = 774), whereas no difference between groups existed for peak V/VO. Logistic regression analysis revealed that VO [0.91, 0.89-0.93; odds ratio (OR), 95% confidence interval (CI)], VO@VT (0.91, 0.87-0.95; OR, 95% CI), OUES (0.32, 0.20-0.52; OR, 95% CI), and V/VCO (1.03, 1.01-1.05 OR, 95% CI) were all associated with the presence of MetSyn ( ≤ 0.001). These results indicate that MetSyn is associated with altered cardiopulomary function that may provide insight into the underlying pathophysiology of MetSyn.
心肺适能(CRF)与代谢综合征(MetSyn)之间的关联已得到充分证实。从心肺运动试验(CPET)得出的其他变量在某些慢性疾病中显示出预后价值,然而,关于MetSyn患者运动时心肺反应如何改变的信息有限。因此,本研究的目的是探讨CPET得出的心肺变量与MetSyn之间的关联。一组3181名年龄在20 - 79岁之间的参与者(1714名男性,1467名女性)在1971年1月1日至2020年11月1日期间完成了CPET和代谢风险因素评估。评估的心肺变量包括定义为最大摄氧量(VO)的CRF、通气阈值(VO@VT)、摄氧效率斜率(OUES)、运动峰值时通气与VO的比值(峰值V/VO)以及V/VCO。MetSyn采用美国国家胆固醇教育计划/成人治疗小组的定义。MetSyn患者(n = 774)的VO、VO@VT和OUES较低(P < 0.001),V/VCO较高(P < 0.001),而峰值V/VO在两组之间无差异。逻辑回归分析显示,VO [0.91, 0.89 - 0.93;比值比(OR),95%置信区间(CI)]、VO@VT(0.91, 0.87 - 0.95;OR,95% CI)、OUES(0.32, 0.20 - 0.52;OR,95% CI)和V/VCO(1.03, 1.01 - 1.05 OR,95% CI)均与MetSyn的存在相关(P ≤ 0.001)。这些结果表明,MetSyn与心肺功能改变有关,这可能有助于深入了解MetSyn的潜在病理生理学。